Name: Global Elapegademase-lvlr Market Research Report 2019
Brand: QYResearch
SKU: Pharma & Healthcare
Price: 2900.00 USD
Availability: InStock
Rating: 3.8 (39 reviews)

Revcovi (elapegademase-lvlr) is a new enzyme replacement therapy indicated for the treatment of adenosine deaminase severe combined immune deficiency (ADA-SCID) in pediatric and adult patients.

In 2018, global revenue of Elapegademase-lvlr is nearly 11 M USD and will be 16.9 million USD, with a CAGR of 3.5% between 2019 and 2025.

This report focuses on Elapegademase-lvlr volume and value at global level, regional level and company level. From a global perspective, this report represents overall Elapegademase-lvlr market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, and Japan.

At company level, this report focuses on the sales, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:

Leadiant Biosciences

Orchard Therapeutics

Teijin Pharma

Segment by Regions

North America

Europe

Japan

Rest of World

Segment by Type

Revcovi

Strimvelis

Adagen

Segment by Application

Pediatric

Adult

Research Approach

This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.

Market Size Estimation

Top-down and bottom-up approaches are used to estimate and validate the global market size for company, regional division, product type and application (end users).

The market estimations in this report are based on the selling price (excluding any discounts provided by the manufacturer, distributor, wholesaler or traders). Market share analysis, assigned to each of the segments and regions are achieved through product utilization rate and average selling price.

Major manufacturers & their revenues, percentage splits, market shares, growth rates and breakdowns of the product markets are determined through secondary sources and verified through the primary sources.

All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or others factors are accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from QYResearch and presented in this report.

The following figure shows an illustrative representation of the overall market size estimation process used for this study.

Market Breakdown and Data Triangulation

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation. Extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report.

Secondary Sources

Secondary Sources occupies approximately 25% of data sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on. This research study includes secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; investor presentations; and SEC filings of companies.

Primary Sources

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.

1 Elapegademase-lvlr Market Overview 1

1.1 Product Overview and Scope of Elapegademase-lvlr 1

1.2 Elapegademase-lvlr Segment by Types 2

1.2.1 Global Elapegademase-lvlr Sales Growth Rate Comparison by Types (2019-2025) 2

1.2.2 Revcovi 4

1.2.3 Strimvelis 4

1.2.4 Adagen 5

1.3 Elapegademase-lvlr Segment by Applications 5

1.3.1 Global Elapegademase-lvlr Sales Comparison by Applications (2014-2025) 5

1.3.2 Pediatric 7

1.3.3 Adult 7

1.4 Global Elapegademase-lvlr Market by Regions 8

1.4.1 Global Elapegademase-lvlr Market Size by Regions 8

1.4.2 North America Elapegademase-lvlr Status and Prospect (2014-2025) 9

1.4.3 Europe Elapegademase-lvlr Status and Prospect (2014-2025) 10

1.4.4 Japan Elapegademase-lvlr Status and Prospect (2014-2025) 11

1.5 Global Elapegademase-lvlr Market Size 12

1.5.1 Global Elapegademase-lvlr Revenue (2014-2025) 12

1.5.2 Global Elapegademase-lvlr Sales (2014-2025) 13

2 Global Elapegademase-lvlr Market Competition by Manufacturers 14

2.1 Global Elapegademase-lvlr Sales Market Share by Manufacturers (2018-2019) 14

2.2 Global Elapegademase-lvlr Revenue Market Share by Manufacturers (2018-2019) 15

2.3 Global Elapegademase-lvlr Average Price by Manufacturers (2018-2019) 17

2.4 Manufacturers Elapegademase-lvlr Headquarters, Establishment Year and Product Types 17

2.5 Elapegademase-lvlr Market Competitive Situation and Trends 18

2.5.1 Elapegademase-lvlr Market Concentration Rate 18

2.5.2 Elapegademase-lvlr Market Share of Top 3 19

2.5.3 Mergers & Acquisitions, Expansion 19

3 Global Elapegademase-lvlr Sales by Regions (2014-2019) 22

3.1 Global Elapegademase-lvlr Sales Market Share by Regions 22

3.2 Global Elapegademase-lvlr Revenue Market Share by Regions (2014-2019) 24

3.3 Global Elapegademase-lvlr Sales, Revenue, Price and Gross Margin (2014-2019) 25

3.4 North America Elapegademase-lvlr Sales 26

3.4.1 North America Elapegademase-lvlr Sales Growth Rate (2014-2019) 26

3.4.2 North America Elapegademase-lvlr Sales, Revenue, Price and Gross Margin (2014-2019) 26

3.5 Europe Elapegademase-lvlr Sales 27

3.5.1 Europe Elapegademase-lvlr Sales Growth Rate (2014-2019) 27

3.5.2 Europe Elapegademase-lvlr Sales, Revenue, Price and Gross Margin (2014-2019) 27

3.6 Japan Elapegademase-lvlr Sales (2014-2019) 28

3.6.1 Japan Elapegademase-lvlr Sales Growth Rate (2014-2019) 28

3.6.2 Japan Elapegademase-lvlr Sales, Revenue, Price and Gross Margin (2014-2019) 28

4 Global Elapegademase-lvlr Sales, Revenue, Price Trend by Types 29

4.1 Global Elapegademase-lvlr Sales Market Share by Types (2014-2019) 29

4.2 Global Elapegademase-lvlr Revenue Market Share by Types (2014-2019) 31

4.3 Global Elapegademase-lvlr Price by Type (2014-2019) 32

4.4 Global Elapegademase-lvlr Sales Growth by Type (2014-2019) 33

5 Global Elapegademase-lvlr Market Analysis by Applications 34

5.1 Global Elapegademase-lvlr Sales Market Share by Applications (2014-2019) 34

5.2 Global Elapegademase-lvlr Consumption Growth Rate by Applications (2014-2019) 36

6 Analysis of Elapegademase-lvlr Industry Key Manufacturers 37

6.1 Leadiant Biosciences 37

6.1.1 Company Profile 37

6.1.2 Product Information 38

6.1.3 Sales, Price, Revenue and Gross Margin 39

6.2 Teijin Pharma 40

6.2.1 Company Profile 40

6.2.2 Product Information 41

6.2.3 Sales, Price, Revenue and Gross Margin 41

6.3 Orchard Therapeutics 42

6.3.1 Company Profile 42

6.3.2 Product Information 43

6.3.3 Sales, Price, Revenue and Gross Margin 44

7 Elapegademase-lvlr Manufacturing Cost Analysis 45

7.1 New Drugs R&D Cost Analysis 45

7.1.1 Clinical Phase Costs 46

7.1.2 Capitalized Costs 47

7.2 Proportion of Manufacturing Cost Structure 48

7.2.1 Raw Materials 48

7.2.2 Labor Cost 48

7.2.2.1 USA Labor Cost Analysis 49

7.2.2.2 Europe Labor Costs Analysis 51

7.2.2.3 Asia Labor Costs Analysis 53

7.2.3 Other Costs Analysis 55

7.2.3.1 USA Cost of Electricity Analysis 56

7.2.3.2 USA Water Cost Analysis 56

7.2.3.3 Europe Cost of Electricity Analysis 57

7.2.3.4 Europe Water Cost Analysis 58

7.2.3.5 China Cost of Electricity Analysis 58

7.2.3.6 China Water Cost Analysis 59

7.3 Manufacturing Process Analysis of New Drugs 60

7.4 Elapegademase-lvlr Industrial Chain Analysis 61

8 Marketing Channel, Distributors and Customers 62

8.1 Marketing Channel 62

8.2 Elapegademase-lvlr Distributors List 64

8.3 Elapegademase-lvlr Customers 65

9 Market Dynamics 67

9.1 Market Trends 67

9.2 Opportunities and Drivers 68

9.3 Challenges 68

9.4 Porter's Five Forces Analysis 69

10 Global Elapegademase-lvlr Market Forecast 70

10.1 Global Elapegademase-lvlr Sales, Revenue Forecast 70

10.1.1 Global Elapegademase-lvlr Sales Growth Rate Forecast (2019-2025) 70

10.1.2 Global Elapegademase-lvlr Revenue and Growth Rate Forecast (2019-2025) 71

10.1.3 Global Elapegademase-lvlr Price and Trend Forecast (2019-2025) 72

10.2 Global Elapegademase-lvlr Sales Forecast by Regions (2019-2025) 72

10.2.1 North America Elapegademase-lvlr Sales, Revenue Forecast (2019-2025) 73

10.2.2 Europe Elapegademase-lvlr Sales, Revenue Forecast (2019-2025) 74

10.2.3 Japan Elapegademase-lvlr Sales, Revenue Forecast (2019-2025) 75

10.3 Global Elapegademase-lvlr Sales, Revenue and Price Forecast by Type (2019-2025) 76

10.4 Global Elapegademase-lvlr Consumption Forecast by Application (2019-2025) 78

11 Research Findings and Conclusion 80

12 Methodology and Data Source 81

12.1 Methodology/Research Approach 81

12.1.1 Research Programs/Design 81

12.1.2 Market Size Estimation 82

12.1.3 Market Breakdown and Data Triangulation 83

12.2 Data Source 85

12.2.1 Secondary Sources 85

12.2.2 Primary Sources 86

12.3 Author List 88

12.4 Disclaimer 89

Figure Product Picture of Elapegademase-lvlr 2

Table Global Elapegademase-lvlr Sales (Unit) Growth Rate Comparison by Types (2019-2025) 2

Figure Global Elapegademase-lvlr Market Share by Type in 2018 & 2025 3

Figure Revcovi Product Picture 4

Figure Strimvelis Product Picture 4

Figure Adagen Product Picture 5

Table Global Elapegademase-lvlr Sales (Unit) Comparison by Applications (2019-2025) 5

Figure Global Elapegademase-lvlr Market Share by Application in 2018 & 2025 6

Figure Pediatric 7

Figure Adult 7

Table Elapegademase-lvlr Market Size Comparison by Regions (2019-2025) (Unit) & (Million US$) 8

Figure Elapegademase-lvlr Market Size Comparison by Regions (2019-2025) 9

Figure North America Elapegademase-lvlr Revenue (Million US$) Growth Rate (2014-2025) 10

Figure Europe Elapegademase-lvlr Revenue (Million US$) Growth Rate (2014-2025) 11

Figure Japan Elapegademase-lvlr Revenue (Million US$) Growth Rate (2014-2025) 12

Figure Global Elapegademase-lvlr Revenue (Million US$) (2014-2025) 13

Figure Global Elapegademase-lvlr Sales (Unit) (2014-2025) 13

Table Key Manufacturers Elapegademase-lvlr Covered in This Study 14

Table Global Elapegademase-lvlr Sales (Unit) of Key Manufacturers (2018-2019) 15

Table Global Elapegademase-lvlr Sales Market Share by Manufacturers (2018-2019) 15

Figure Elapegademase-lvlr Sales Share by Manufacturers in 2018 15

Table Global Elapegademase-lvlr Revenue (Million US$) by Manufacturers (2018-2019) 16

Table Global Elapegademase-lvlr Revenue Share by Manufacturers (2018-2019) 16

Figure Global Elapegademase-lvlr Revenue Share by Manufacturers in 2018 16

Table Global Market Elapegademase-lvlr Average Price (USD/Unit) of Key Manufacturers (2018-2019) 17

Table Manufacturers Elapegademase-lvlr Headquarters and Establishment Year 17

Table Manufacturers Elapegademase-lvlr Product Types 17

Table Global Manufacturers Market Concentration Ratio 18

Figure Elapegademase-lvlr Market Share of Top 3 Manufacturers 19

Table Mergers & Acquisitions, Expansion Plans 19

Table Global Elapegademase-lvlr Sales (Unit) by Regions (2014-2019) 22

Table Global Elapegademase-lvlr Sales Market Share by Regions (2014-2019) 22

Figure Global Elapegademase-lvlr Sales Market Share by Regions (2014-2019) 23

Figure Global Elapegademase-lvlr Sales Market Share by Regions in 2018 23

Table Global Elapegademase-lvlr Revenue (Million US$) by Regions (2014-2019) 24

Table Global Elapegademase-lvlr Revenue Market Share by Regions (2014-2019) 24

Figure Global Elapegademase-lvlr Revenue Market Share by Regions (2014-2019) 24

Figure Global Elapegademase-lvlr Revenue Market Share by Regions in 2018 25

Table Global Elapegademase-lvlr Sales (Unit), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019) 25

Figure North America Elapegademase-lvlr Sales (Unit) Growth Rate (2014-2019) 26

Table North America Elapegademase-lvlr Sales (Unit), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019) 26

Figure Europe Elapegademase-lvlr Sales (Unit) Growth Rate (2014-2019) 27

Table Europe Elapegademase-lvlr Sales (Unit), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019) 27

Figure Japan Elapegademase-lvlr Sales (Unit) Growth Rate (2014-2019) 28

Table Japan Elapegademase-lvlr Sales (Unit), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019) 28

Table Global Elapegademase-lvlr Sales (Unit) by Types (2014-2019) 29

Table Global Elapegademase-lvlr Sales Market Share by Types (2014-2019) 29

Figure Sales Market Share of Elapegademase-lvlr by Types (2014-2019) 30

Figure Sales Market Share of Elapegademase-lvlr by Types in 2018 30

Table Global Elapegademase-lvlr Revenue (Million US$) by Types (2014-2019) 31

Table Global Elapegademase-lvlr Revenue Share by Types (2014-2019) 31

Figure Revenue Share of Elapegademase-lvlr by Types (2014-2019) 31

Figure Revenue Market Share of Elapegademase-lvlr by Types in 2018 32

Table Global Elapegademase-lvlr Price (USD/Unit) by Types (2014-2019) 32

Figure Global Elapegademase-lvlr Sales Growth by Type (2014-2019) 33

Table Global Elapegademase-lvlr Sales (Unit) by Applications (2014-2019) 34

Table Global Elapegademase-lvlr Sales Market Share by Applications (2014-2019) 34

Figure Global Elapegademase-lvlr Sales Market Share by Applications (2014-2019) 35

Figure Global Elapegademase-lvlr Sales Market Share by Applications in 2018 35

Figure Global Elapegademase-lvlr Consumption Growth Rate by Applications (2014-2019) 36

Table Leadiant Biosciences Company Profile 37

Table Elapegademase-lvlr Product Picture of Leadiant Biosciences 38

Table Elapegademase-lvlr Sales (Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Leadiant Biosciences 2018-2019 39

Table Teijin Pharma Company Profile 40

Table Revcovi Product Picture of Teijin Pharma 41

Table Elapegademase-lvlr Sales (Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Teijin Pharma 2018-2019 41

Table Orchard Therapeutics Company Profile 42

Table Strimvelis Product Picture of Orchard Therapeutics 43

Table Elapegademase-lvlr Sales (Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Orchard Therapeutics 2018-2019 44

Figure Typical Phases from Research to the Market for a Drug Candidate 46

Table Out-of-pocket Preclinical and Clinical Period Cost Per Investigational Biopharmaceutical Compound 47

Table Capitalized Preclinical and Clinical Period costs per Investigational Biopharmaceutical Compound 48

Figure Manufacturing Cost Structure of Compounding Pharmacy 48

Figure USA Labor Cost Analysis 2015-2018 49

Figure Cost of Employing a Factory Worker 50

Figure Europe Labor Cost Analysis 2015-2018 51

Figure Germany Labor Cost Analysis 2015-2018 51

Figure UK Labor Cost Analysis 2015-2018 52

Figure France Labor Cost Analysis 2015-2018 52

Figure Italy Labor Cost Analysis 2015-2018 53

Figure Monthly Minimum Wages in Asia 2016 53

Figure China Labor Costs 2015-2018 54

Figure Japan Average Monthly Wages 2015-2018 54

Figure Global Electricity Prices by Select Countries in 2017 (in U.S. Dollars per Kilowatt Hour) 55

Table Average Price of Electricity to Ultimate Customers 2007-2018 56

Figure Electricity Prices for Household Consumers in 2017 57

Table China Cost of Electricity 2017 (PER KWH) 58

Figure Manufacturing Process Analysis of New Drugs 60

Figure Elapegademase-lvlr Industrial Chain Analysis 61

Figure Channels of Distribution 63

Table Elapegademase-lvlr Distributors List 64

Figure Distributors Profiles 64

Table Market Key Trends 67

Table Key Opportunities and Drivers: Impact Analysis (2019-2025) 68

Table Key Challenges 68

Figure Porter's Five Forces Analysis 69

Figure Global Elapegademase-lvlr Sales (Unit) Growth Rate Forecast (2019-2025) 70

Figure Global Elapegademase-lvlr Revenue (Million US$) Growth Rate Forecast (2019-2025) 71

Figure Global Elapegademase-lvlr Price (USD/Unit) and Trend Forecast (2019-2025) 72

Table Global Elapegademase-lvlr Sales (Unit) Forecast by Regions (2019-2025) 72

Figure Global Elapegademase-lvlr Sales Market Share Forecast by Regions (2019-2025) 73

Figure North America Elapegademase-lvlr Sales (Unit) Growth Rate Forecast (2019-2025) 73

Figure North America Elapegademase-lvlr Revenue (Million US$) Growth Rate Forecast (2019-2025) 74

Figure Europe Elapegademase-lvlr Sales (Unit) Growth Rate Forecast (2019-2025) 74

Figure Europe Elapegademase-lvlr Revenue (Million US$) Growth Rate Forecast (2019-2025) 75

Figure Japan Elapegademase-lvlr Sales (Unit) Growth Rate Forecast (2019-2025) 75

Figure Japan Elapegademase-lvlr Revenue (Million US$) Growth Rate Forecast (2019-2025) 76

Table Global Elapegademase-lvlr Sales (Unit) Forecast by Type (2019-2025) 76

Figure Global Elapegademase-lvlr Sales Market Share Forecast by Type (2019-2025) 77

Table Global Elapegademase-lvlr Revenue (Million US$) Forecast by Type (2019-2025) 77

Figure Global Elapegademase-lvlr Revenue Market Share Forecast by Type (2019-2025) 78

Table Global Elapegademase-lvlr Price (USD/Unit) Forecast by Type (2019-2025) 78

Table Global Elapegademase-lvlr Sales (Unit) Forecast by Application (2019-2025) 78

Figure Global Elapegademase-lvlr Consumption Market Share Forecast by Application (2019-2025) 79

Table Research Programs/Design for This Report 81

Figure Bottom-up and Top-down Approaches for This Report 83

Figure Data Triangulation 84

Figure Key Executives Interviewed 85

Table Key Data Information from Secondary Sources 86

Table Key Data Information from Primary Sources 87

Licenses Type

USD 2,900 Single License

Only one user can access the report

USD 5,800 Enterprise License

Multiple users can access the report

Global Elapegademase-lvlr Market Research Report 2019

Research Approach

Market Size Estimation

The following figure shows an illustrative representation of the overall market size estimation process used for this study.

Market Breakdown and Data Triangulation

Secondary Sources

Primary Sources

Global 3D Printing Healthcare Industry Research Report, Growth Trends and Competitive Analysis 2021-2027

Global 3D Printed Drugs Industry Research Report, Growth Trends and Competitive Analysis 2021-2027

Global Systemic Infection Therapy Industry Research Report, Growth Trends and Competitive Analysis 2021-2027

Global Syringe Trays Industry Research Report, Growth Trends and Competitive Analysis 2021-2027

Global Surgical & Operating Microscopes Industry Research Report, Growth Trends and Competitive Analysis 2021-2027

Licenses Type

Why QYR

Fastest report delivery service

More than 10 years of vast experience

Operational for **24 * 7 & 365 days**

In-depth and comprehensive analysis

Excellent after sales support

Owns large database

Need Help ?